Salim Yusuf
Salim Yusuf
Population Health Research Institute, McMaster University and Hamilton Health Sciences
Geverifieerd e-mailadres voor mcmaster.ca - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
52510*2015
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
18389*2004
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
12297*2002
Dabigatran versus warfarin in patients with atrial fibrillation
SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ...
New England Journal of Medicine 361 (12), 1139-1151, 2009
122102009
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
79472001
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais
The New England journal of medicine 342 (3), 145-153, 2000
78372000
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed†…
Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ...
European heart journal 33 (21), 2719-2747, 2012
61072012
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta, S Yusuf, RJG Peters, ME Bertrand, BS Lewis, MK Natarajan, ...
The Lancet 358 (9281), 527-533, 2001
42102001
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
SOLVD Investigators*
New England Journal of Medicine 327 (10), 685-691, 1992
40271992
Beta blockade during and after myocardial infarction: an overview of the randomized trials
S Yusuf, R Peto, J Lewis, R Collins, P Sleight
Progress in cardiovascular diseases 27 (5), 335-371, 1985
38831985
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ...
Lancet (London, England) 376 (9753), 1670-1681, 2010
37572010
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
The lancet 355 (9200), 253-259, 2000
36722000
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
S Yusuf, S Hawken, S Ounpuu, L Bautista, MG Franzosi, P Commerford, ...
The Lancet 366 (9497), 1640-1649, 2005
34732005
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ...
The Lancet 376 (9735), 112-123, 2010
34492010
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
S Yusuf, MA Pfeffer, K Swedberg, CB Granger, P Held, JJV McMurray, ...
The Lancet 362 (9386), 777-781, 2003
31512003
The effect of digoxin on mortality and morbidity in patients with heart failure
Digitalis Investigation Group
New England Journal of Medicine 336 (8), 525-533, 1997
31191997
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events†…
HG Site
Lancet 367 (9526), 1903-1912, 2006
2894*2006
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
New England Journal of Medicine 364 (9), 806-817, 2011
28882011
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen, B Hoogwerf, ...
Jama 286 (4), 421-426, 2001
28862001
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
A Rosengren, S Hawken, S ‘unpuu, K Sliwa, M Zubaid, WA Almahmeed, ...
The Lancet 364 (9438), 953-962, 2004
26822004
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20